📣 Registration for #ESMOTATAsia26 is open! Join global experts in #precisiononcology and discover the latest breakthroughs in cancer #drugdevelopment

🔗 https://ow.ly/oQRg50XBOZZ

⏰ Early Registration applies until 8 April 2026.

👏 Congratulations to the #ESMOMeritAward recipients at #ESMOTATAsia26.
These young researchers were recognised for the scientific merit of their abstracts
➡️ https://ow.ly/SE0V50Z8ECu

📣 On-demand sessions from #ESMOTATAsia26 are now live on OncologyPRO.

📌 Available where speaker permission has been granted
👉 Watch now: https://ow.ly/c00r50ZaYEt

#ESMOMeetings #TargetedTherapies #Oncology

🙌 ESMO TAT Asia 2026 has officially begun. Over the next three days, experts across research and clinical oncology share the latest in translational science.

Join the #ESMOTATAsia26 conversation.

👉 https://ow.ly/Mv4f50ZalFm

#ESMOMeetings #Oncology #CancerResearch

#ESMOTATAsia26: Two novel CD47-SIRPα axis #FusionProteins with reduced haematological toxicity show promise in early-phase #ClinicalTrials in patients with heavily pre-treated #SolidTumours. More details in the #ESMODailyReporter: https://ow.ly/1MqO50ZbpBh

#ESMOTATAsia26: HRP-Fusion model captures #TumourHeterogeneity within #HER2-positive #BreastCancer lesions, using #DigitalOncology to improve pathological complete response prediction and help advance #PrecisionOncology. #ESMODailyReporter: ➡️ https://ow.ly/gqI950Zb2Bl

⏳ Still time to join #ESMOTATAsia26

Be part of ESMO Targeted Anticancer Therapies Asia 2026, a key Asia Pacific forum for cancer drug development.

👉 Register by 3 June and save: https://ow.ly/WKAw50Z4GEK

#ESMOMeetings

🎥 Hear from Prof. Brigette Ma, Prof. Ravindran Kanesvaran, Prof. Stephen Chan, and Dr. Janice Tsang on why #ESMOTATAsia26 matters for translational oncology in Asia‑Pacific.
⏳ Late Registration closes 13 May
👉 Register now: https://ow.ly/quVK50YV0zE

#ESMOMeetings #TargetedTherapies